Categories: News

Eargo to Report Third Quarter 2022 Financial Results on November 3, 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN JOSE, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) — Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the third quarter 2022 after market close on November 3, 2022. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (888)-599-8686 for domestic callers or (323)-794-2588 for international callers, using conference ID: 8304019. The live webinar of the call may also be accessed by visiting the Events and Presentations section of Eargo’s website at ir.eargo.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Eargo’s website for one year.

About Eargo
Eargo is a medical device company on a mission to improve hearing health. Our innovative products and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first virtually invisible, rechargeable, completely-in-canal, FDA-regulated, Class I or Class II exempt devices indicated to compensate for mild to moderate hearing loss. Our differentiated, consumer-first approach empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from hearing professionals via phone, text, email or video chat. The Eargo device is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.

Eargo’s sixth generation device, Eargo 6, is an FDA Class II exempt hearing device featuring Sound Adjust technology that automatically optimizes the soundscape as the user moves between environments. Eargo 6 is available for purchase here.

Related Links
http://eargo.com

Investor Contact
Nick Laudico
Senior Vice President of Corporate Strategy and Investor Relations
ir@eargo.com

Staff

Recent Posts

Hexaware Accelerates Delivery Solutions with a New Office in Chicago

CHICAGO, May 22, 2025 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a leading global IT services…

59 minutes ago

Bulletin from the Annual General Meeting 2025

The Annual General Meeting 2025 of RaySearch Laboratories AB (publ) was held on May 22, 2025,…

59 minutes ago

Lofta and Bloom Mental Health Partner to Bridge the Gap Between Sleep Apnea and Mental Health

SAN DIEGO, May 22, 2025 /PRNewswire/ -- Lofta, a leader in at-home sleep apnea testing…

60 minutes ago

AMA Establishes CPT Codes for Minimally Invasive ESD Procedure

CENTER VALLEY, Pa., May 22, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company…

60 minutes ago

Tap Native Launches Precision Bidding by NPI, Empowering Pharma Marketers to Reach HCPs at the Individual Level

RAMSEY, N.J., May 22, 2025 /PRNewswire/ -- Tap Native, a leading healthcare-focused digital advertising platform,…

60 minutes ago

Former Amazon Leaders Launch General Medicine: A Healthcare Store That Gives Everyone Access to the Best Care in the World

General Medicine aims to make healthcare as easy as shopping online, while making sure customers…

60 minutes ago